Thanks GreenBioAnalyst! I am not a scientist so my question to you is if B gets the ok to go forward with Covid19 in human trials; will B go to phase 2 or 3? My understanding is that phase 2 deals with mostly efficacy/dosing/effectiveness? That would have been figured out in the other B phase 2 trials. Any thoughts/opinion on this?
Go Leo & IPIX!
"I'm looking here and I see a lot of petrified shorts, "parasites, " and "criminals" who are planting fear, and uncertainty for you to sell your shares for cheap. Don't let them fool you.
Some are pretending to be bulls, and you can tell how they just wreak with fear and uncertainty of how they're about to lose everything. Should you feel pity and remorse for these stained " criminals"? I don't think you should. Not at all.
As always, just like any previous in vivo assays, I highly doubt the narratives will change anything than proving, yet again, that amplification of Bril in human epithelial lungs inhibits SARS-CoV-2 viral load, replication, and induces anti-inflammatory properties in cytokine reductions. Bril's 3-in-1 action is no joke!
The bears or shorts flipped and shorted this company with impunity and no mercy without really understanding how the science behind Bril actually will work against the CV19 pandemic. Now, Bril has multiple options such as a mono therapeutic drug, prophylaxis, an adjunct to another HIV drug, and/or an adjuvant to a future vaccine( JNJ and BARDA?). Best yet, funding from the government and a potential partnership. I can't wait for them to announce when the IND application is to go along with PII/PIII trials.
This is a hidden gem. This company will trade over $1 and much higher very soon! Jmho. YOU guys earned it for sticking through it. GLTAL!"
